logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Patel, Nitinkumar Ramanlal
    Finance Director born in February 1967
    Individual (6 offsprings)
    Officer
    2016-07-15 ~ 2017-06-02
    OF - Director → CIF 0
  • 2
    Parikh, Samir Haresh
    Born in January 1973
    Individual (9 offsprings)
    Officer
    2012-11-12 ~ now
    OF - Director → CIF 0
    Mr Samir Haresh Parikh
    Born in January 1973
    Individual (9 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Has significant influence or control over the trustees of a trustCIF 0
  • 3
    Pinto Emms, Juliana Cristina
    Born in April 1979
    Individual (1 offspring)
    Officer
    2022-12-21 ~ now
    OF - Director → CIF 0
  • 4
    PRIMANEX LIMITED
    09841244
    506, Kingsbury Road, London, England
    Active Corporate (2 parents, 3 offsprings)
    Person with significant control
    2017-06-02 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

NEXCAPE PHARMACEUTICALS LTD

Period: 2012-11-12 ~ now
Company number: 08290141
Registered name
NEXCAPE PHARMACEUTICALS LTD - now
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Par Value of Share
Class 1 ordinary share
02024-04-01 ~ 2025-03-31
Intangible Assets
3,526 GBP2025-03-31
2,700 GBP2024-03-31
Property, Plant & Equipment
445,549 GBP2025-03-31
416,629 GBP2024-03-31
Fixed Assets
449,075 GBP2025-03-31
419,329 GBP2024-03-31
Total Inventories
427,624 GBP2025-03-31
247,397 GBP2024-03-31
Debtors
3,019,157 GBP2025-03-31
1,818,292 GBP2024-03-31
Cash at bank and in hand
129,188 GBP2025-03-31
5,482 GBP2024-03-31
Current Assets
3,575,969 GBP2025-03-31
2,071,171 GBP2024-03-31
Creditors
Current
-3,643,215 GBP2025-03-31
-2,171,805 GBP2024-03-31
Net Current Assets/Liabilities
-67,246 GBP2025-03-31
-100,634 GBP2024-03-31
Total Assets Less Current Liabilities
381,829 GBP2025-03-31
318,695 GBP2024-03-31
Creditors
Non-current
-218,102 GBP2025-03-31
-272,175 GBP2024-03-31
Net Assets/Liabilities
157,638 GBP2025-03-31
45,925 GBP2024-03-31
Equity
Called up share capital
10,000 GBP2025-03-31
10,000 GBP2024-03-31
Retained earnings (accumulated losses)
147,638 GBP2025-03-31
35,925 GBP2024-03-31
Equity
157,638 GBP2025-03-31
45,925 GBP2024-03-31
Average Number of Employees
52024-04-01 ~ 2025-03-31
62023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
69,477 GBP2025-03-31
65,489 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
65,951 GBP2025-03-31
62,789 GBP2024-03-31
Intangible Assets - Increase From Amortisation Charge for Year
3,162 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Gross Cost
518,781 GBP2025-03-31
483,931 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
73,232 GBP2025-03-31
67,302 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
5,930 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000,000 shares2025-03-31
Profit/Loss
Retained earnings (accumulated losses)
117,213 GBP2024-04-01 ~ 2025-03-31
Dividends Paid
Retained earnings (accumulated losses)
-5,500 GBP2024-04-01 ~ 2025-03-31

Related profiles found in government register
  • NEXCAPE PHARMACEUTICALS LTD
    Info
    Registered number 08290141
    20-22 Wenlock Road, London N1 7GU
    PRIVATE LIMITED COMPANY incorporated on 2012-11-12 (13 years 7 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-06-06
    CIF 0
  • NEXCAPE PHARMACEUTICALS LTD
    S
    Registered number 08290141
    20-22, Wenlock Road, London, England, N1 7GU
    Limited Company in Companies House, England & Wales
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    LIQUIDSUN LTD
    10229217
    15 Martinfield Business Centre, Welwyn Garden City, Hertfordshire, England
    Active Corporate (4 parents)
    Person with significant control
    2016-06-13 ~ 2017-09-01
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.